Singapore markets close in 7 hours 44 minutes

Straits Times Index
3,310.20
+5.21(+0.16%)
Nikkei
38,567.02
-353.24(-0.91%)
Hang Seng
19,376.53
0.00(0.00%)
FTSE 100
8,438.65
-7.15(-0.08%)
Bitcoin USD
65,302.11
-801.20(-1.21%)
CMC Crypto 200
1,377.26
-16.78(-1.21%)

GILD Jun 2025 65.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

8.35

-0.10

(-1.18%)

As of 01:25PM EDT. Market open.

Loading interactive chart…

Business Wire
Kite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy
SANTA MONICA, Calif., May 14, 2024--Kite, a Gilead Company (Nasdaq: GILD), today announced 12 abstracts from its industry-leading Chimeric Antigen Receptor (CAR) T-cell therapy portfolio at the upcoming 2024 European Hematology Association (EHA) Annual Congress, June 13-16, Madrid, Spain.
Yahoo Finance
One stock is dragging down the S&P 500's earnings growth
S&P 500 companies have had a solid Q1 earnings season, with one key exception: drugmaker Bristol Myers Squibb.
Zacks
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Gilead (GILD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.